Hepatotoxicity associated with sustained-release niacin.

Abstract

Niacin (nicotinic acid) is a widely used agent in the treatment of hyperlipidemias characterized by elevated low-density lipoprotein and very-low-density lipoprotein. The tendency of the conventional crystalline niacin to cause flushing has limited its use in many patients. Sustained-release (SR) niacin preparations are increasingly utilized due to a lower… (More)

Topics

Cite this paper

@article{Dalton1992HepatotoxicityAW, title={Hepatotoxicity associated with sustained-release niacin.}, author={Teresa A Dalton and Ryan S. Berry}, journal={The American journal of medicine}, year={1992}, volume={93 1}, pages={102-4} }